Price T Rowe Associates Inc Day One Biopharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,544,863 shares of DAWN stock, worth $33.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,544,863

Previous 2,350,880 8.25%

Holding current value

$33.1 Million

Previous $32.4 Million 9.43%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$12.72 - $16.03 $2.47 Million - $3.11 Million	193,983 Added 8.25%	2,544,863 $35.5 Million
Q2 2024 Aug 14, 2024	BUY	$12.03 - $17.69 $614,925 - $904,242	51,116 Added 2.22%	2,350,880 $32.4 Million
Q1 2024 May 15, 2024	SELL	$13.56 - $17.46 $230,520 - $296,820	-17,000 Reduced 0.73%	2,299,764 $38 Million
Q4 2023 Feb 14, 2024	BUY	$9.68 - $15.37 $84,564 - $134,272	8,736 Added 0.38%	2,316,764 $33.8 Million
Q3 2023 Nov 14, 2023	SELL	$11.22 - $14.86 $19,107 - $25,306	-1,703 Reduced 0.07%	2,308,028 $28.3 Million
Q2 2023 Aug 14, 2023	BUY	$11.74 - $14.47 $7.57 Million - $9.33 Million	644,980 Added 38.74%	2,309,731 $27.6 Million
Q1 2023 May 15, 2023	SELL	$12.75 - $23.41 $6.6 Million - $12.1 Million	-517,827 Reduced 23.73%	1,664,751 $22.3 Million
Q4 2022 Feb 14, 2023	BUY	$18.77 - $22.0 $1.65 Million - $1.93 Million	87,665 Added 4.18%	2,182,578 $47 Million
Q3 2022 Nov 14, 2022	BUY	$16.44 - $26.57 $880,674 - $1.42 Million	53,569 Added 2.62%	2,094,913 $42 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $17.9 $2.61 Million - $8.16 Million	455,603 Added 28.73%	2,041,344 $36.5 Million
Q1 2022 May 16, 2022	BUY	$9.12 - $17.47 $43,438 - $83,209	4,763 Added 0.3%	1,585,741 $15.7 Million
Q4 2021 Feb 14, 2022	BUY	$15.65 - $26.33 $1.17 Million - $1.97 Million	74,652 Added 4.96%	1,580,978 $26.6 Million
Q3 2021 Nov 15, 2021	BUY	$20.0 - $27.92 $18,600 - $25,965	930 Added 0.06%	1,506,326 $34.9 Million
Q2 2021 Aug 16, 2021	BUY	$19.0 - $23.69 $28.6 Million - $35.7 Million	1,505,396 New	1,505,396 $33.4 Million

Others Institutions Holding DAWN

# of Institutions

181

Shares Held

84.2M

Call Options Held

148K

Put Options Held

218K

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $956M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Day One Biopharmaceuticals, Inc. Transaction History